Advertisement

Topics

Astellas Pharma Global Development Company Profile

09:03 EDT 26th September 2017 | BioPortfolio

Astellas Pharma Global Development, located in Deerfield, Illinois, is a group company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. For more information about Astellas Pharma Inc., please visit the website at http://www.astellas.com/en/.


News Articles [11824 Associated News Articles listed on BioPortfolio]

Astellas Supports the Northern Kyushu Heavy Rain Relief Efforts

Tokyo, July 13, 2017– Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) would like to express our deepest sympathy to the victims of the heavy rain hit to No...

Astellas AML Inhibitor Granted Orphan Drug Designation

NewsU.S. FDA grants orphan-drug designation to Astellas for development of FLT3 inhibitor gilteritinib in acute myeloid leukemia.

Astellas discontinues development of lung cancer candidate ASP8273

Japanese drug major Astellas Pharma says it is discontinuing the ASP8273 treatment arm in the late-stage…

ABPI Extends Suspension of Astellas UK

The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its Code of Pract...

LTL Pharma Succeeds Marketing Approval for "Nivadil® Tablets", "Solantal® Tablets" and "Lowgan® Tablets", and isTransferred Distribution Rights in Japan

Tokyo (Japan), August 1, 2017 –LTL Pharma Co., Ltd. (Representative Director, Chairman: Sansei Oka, Representative Director, President: Jiro Mizukawa, “LTL Pharma”) and Astellas Ph...

Promotions at Astellas in the USA

Japanese pharma major Astellas Pharma today announced two senior-level promotions in its Marketing Strategy…

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance ReportSummaryAstellas Pharma Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. Th...

Astellas Discontinues Development of its Late-Stage Non-Small Cell Lung Cancer Candidate

TOKYO, May 10, 2017 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) announced today the discontinuation of ASP8273 treatment arm in...

Drugs and Medications [362 Associated Drugs and Medications listed on BioPortfolio]

Vesicare [Astellas Pharma Technologies, Inc.]

These highlights do not include all the information needed to use VESIcare safely and effectively. See full prescribing information for VESIcare. VESIcare (solifenacin succinate) tablets Initial U.S. ...

Azelastine hydrochloride [Sun Pharma Global FZE]

Azelastine Hydrochloride Ophthalmic Solution, 0.05%

Chlorothiazide sodium [Sun Pharma Global FZE]

Chlorothiazide Sodium for Injection, USPFOR THE PREPARATION OF INTRAVENOUS SOLUTIONS

Galantamine hydrobromide [Sun Pharma Global FZE]

Galantamine Hydrobromide Extended-Release Capsules

Gemcitabine [Sun Pharma Global FZE]

These highlights do not include all the information needed to use gemcitabine safely and effectively. See full prescribing information for gemcitabine for injection. Gemcitabine for Injection USP, Pow...

PubMed Articles [3117 Associated PubMed Articles listed on BioPortfolio]

The strategic geographies of global health partnerships.

Global health partnerships have been hailed as a means of addressing the global health worker shortage, bringing forth health systems strengthening and, therefore, the universal health coverage aspira...

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.

An adequate amount of prepaid resources for health is important to ensure access to health services and for the pursuit of universal health coverage. Previous studies on global health financing have d...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Valbenazine: First Global Approval.

Valbenazine (Ingrezza™) is an orally bioavailable, selective, vesicular monoamine transporter 2 (VMAT2) inhibitor being developed by Neurocrine Biosciences for the treatment of various central nervo...

Clinical Trials [2195 Associated Clinical Trials listed on BioPortfolio]

AMEVIVE® Pregnancy Registry

This is an observational, exposure-registration and follow-up study, to be conducted in the United States (US). The AMEVIVE® Pregnancy Exposure Registry is designed to monitor pregnant s...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 5 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

The purpose of the study is to provide access to continued treatment for subjects who participated in other Astellas sponsored ASP2215 trials and for whom the Investigator feels the subjec...

Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

The objective of the study is to demonstrate bioequivalence between Test Product (A): Tacrolimus Capsules 1 mg, manufactured by Panacea Biotec Limited, India and the corresponding Referenc...

Companies [2528 Associated Companies listed on BioPortfolio]

Astellas Pharma Global Development

Astellas Pharma Global Development, located in Deerfield, Illinois, is a group company of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of peo...

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

Potenza Therapeutics, Inc.

Astellas Pharma Inc., located in Tokyo, Japan, is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and rel...

More Information about "Astellas Pharma Global Development" on BioPortfolio

We have published hundreds of Astellas Pharma Global Development news stories on BioPortfolio along with dozens of Astellas Pharma Global Development Clinical Trials and PubMed Articles about Astellas Pharma Global Development for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Astellas Pharma Global Development Companies in our database. You can also find out about relevant Astellas Pharma Global Development Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record